newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

business / news / / CNBC

U.S. drugmaker Eli Lilly is in advanced talks to acquire biotech firm Kelonia Therapeutics for more than $2 billion.

Eli Lilly is in advanced negotiations to acquire Kelonia Therapeutics for over $2 billion.

KEY POINTS
COMPANIES
Read the full story on CNBC →
Share X LinkedIn

Summarized by Newsio from CNBC. How we summarize →